Results 71 to 80 of about 963 (180)

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF BILASTINE AND MONTELUKAST IN COMBINED DOSAGE FORM

, 2023
A rapid and precise reverse phase high performance liquid chromatographic method has been developed for the validated of Montelukast and Bilastine, in its pure form as well as in tablet dosage form.
P. Jyothi *, V. Soumya
core   +1 more source

Development and characterization of bilastine nanosuspension for enhanced dissolution in orodispersible films

OpenNano
Bilastine, a second-generation antihistamine, is commonly prescribed for managing allergic rhinoconjunctivitis and urticaria due to its prolonged action.
Sarah Adnan Oudah, Eman B.H. Al-Khedairy
doaj   +1 more source

Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria

, 2016
Maria T Staevska Clinical Center of Allergology, Medical University, Sofia, Bulgaria As a group of allergists who treat both allergic rhinitis and urticaria patients on a daily basis, and involved in clinical research, we read with particular ...
Staevska MT
core  

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine

Therapeutics and Clinical Risk Management, 2016
Xue Yan Wang,1 Margaret Lim-Jurado,2 Narayanan Prepageran,3 Pongsakorn Tantilipikorn,4 De Yun Wang5 1Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2St Luke’s Medical Center,
Wang XY, Lim-Jurado M, Prepageran N, Tantilipikorn P, Wang DY   +4 more
doaj  

Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review

, 2011
Background: The ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines development group examined the properties of oral H-1-antihistamines and made proposals about an 'optimal' drug.
Piotr Kuna, Claus Bachert, Alvaro A. Cruz, Dermot P. Ryan, Zuberbier T, Cruz, Alvaro A, Sánchez Borges M, Canonica, G Walter, Morais-Almeida, Mario, Torsten Zuberbier, Mullol, Joaquim, Church MK, Baena Cagnani CE, González, Sandra N, Sandra N. González, González SN, Ryan DP, Bousquet, Jean, Mario Morais-Almeida, Ansótegui I, Carlos E. Baena-Cagnani, Joaquim Mullol, Morais Almeida M, Zuberbier, Torsten, Church, Martin K, G. Walter Canonica, Bachert, Claus, Ryan, Dermot P, Mullol J, Bousquet J, Valiente, Román, Ignacio Ansótegui, Mario Sánchez-Borges, Sánchez-Borges, Mario, CANONICA, GIORGIO, Baena-Cagnani, Carlos E, Valiente R, Kuna P, Kuna, Piotr, Ansótegui, Ignacio, Jean Bousquet, Román Valiente, Bachert C, Martin K. Church, Cruz AA   +44 more
core   +1 more source

Application of physiologically‐based pharmacokinetic modeling to inform dosing decisions for geriatric patients

CPT: Pharmacometrics &Systems Pharmacology, Volume 13, Issue 12, Page 2031-2035, December 2024.
Lixuan Qian, Ziteng Wang, Mary F. Paine, Eric Chun Yong Chan, Zhu Zhou   +4 more
wiley   +1 more source

New possibilities for symptomatic treatment of allergic rhinitis

Медицинский совет, 2019
Allergic rhinitis is one of the most common human diseases and causes a deterioration of the quality of life. The prevalence of allergic rhinitis in the Russian Federation and in the world has increased significantly.
S. V. Ryazantsev, A. A. Krivopalov, S. A. Rebrova, L. I. Krivopalova   +3 more
doaj   +1 more source

Bilastine and quality of life.

Journal of investigational allergology & clinical immunology, 2012
The evaluation of quality of life (QoL) and its modification through therapeutic interventions has become a prioritary concern in recent years and a requirement on the part of regulatory agencies for the authorization of new drugs. In clinical studies of allergic disorders, particularly allergic rhinitis and urticaria, different types of generic ...
I, Jáuregui, J, Bartra, A, del Cuvillo, I, Dávila, M, Ferrer, J, Montoro, J, Mullol, J, Sastre, A, Valero   +8 more
openaire   +1 more source

Efficacy of bilastine up-dosing (40 mg) versus combination of bilastine 20 mg with levocetirizine 5 mg in the treatment of chronic spontaneous urticaria:a prospective randomized controlled study

Objective: To compare the efficacy of bilastine up-dosing (40 mg/day) with combination therapy consisting of bilastine 20 mg and levocetirizine 5 mg in patients with chronic spontaneous urticaria (CSU). Study Design: Randomized controlled trial.
Irfan Anwar, Sana Zafar, Ayesha Kanwal, Atika Raheem, Iqra Naseem, Ayesha Anwar   +5 more
core   +1 more source

Role of bilastine in allergic rhinitis: a review

International Journal of Otorhinolaryngology and Head and Neck Surgery, 2020
<p class="abstract">The prevalence of allergic diseases is increasing globally, most particularly in middle to low-income countries. Allergic rhinitis and urticaria are common allergic diseases that may have a major negative impact on patient’s quality of life.
openaire   +2 more sources